SI-BONE, a medical device company that focuses on the development of minimally invasive surgical devices, announced today more than 3,000 patients have been implanted with its iFuse Implant System. The iFuse is a titanium implant coated with a porous plasma spray acting as an interference surface fit to decrease implant motion. SI-BONE received original clearance in November 2008 from the FDA to market iFuse and an updated clearance in April 2011 for additional conditions including sacroiliac joint disruptions and degenerative sacroiliitis. The CE mark for European commercialization was obtained in November 2010.
More Articles on Orthopedic Devices:
20 Spine Devices Receive FDA 510(k) Clearance in June
Maxx Medical's Freedom Total Knee System Now Available in China